Gisela Díaz‐Cordovés Rego

Anti–Interleukin‐6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty‐Five Patients

V. Calvo-Río, Inmaculada Calvo, María Isabel González et al. · Arthritis & Rheumatology · 2016 · 150 citations

Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

N. Vegas-Revenga, V. Calvo-Río, Marina Mesquida et al. · American Journal of Ophthalmology · 2019 · 111 citations · Full text

Ocular Disease, Ophthalmology, Anti-il6-receptor Tocilizumab +5

Effectiveness, predictive response factors, and safety of anti-tumor necrosis factor (TNF) therapies in anti-TNF-naive rheumatoid arthritis.

Antonio Fernández‐Nebro, María Victoria Irigoyen, Inmaculada Ureña‐Garnica et al. · PubMed · 2007 · 49 citations

Adiposity Is Related to Inflammatory Disease Activity in Juvenile Idiopathic Arthritis

Gisela Díaz‐Cordovés Rego, Esmeralda Núñez Cuadros, Natalia Mena‐Vázquez et al. · Journal of Clinical Medicine · 2021 · 12 citations · Full text

AB0113 Efficacy of treatment with probiotics in the inflammatory activity of patients with rheumatoid arthritis. systematic review of the literature

C. Fuego, Natalia Mena‐Vázquez, Raquel Caparrós-Ruiz et al. · Annals of the Rheumatic Diseases · 2018 · 11 citations · Full text